The FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU) in patients 12 years and older, the first new ...

A urticaria rash can either be a nonimmune response to ... antihistamines or topical corticosteroids for more severe or painful reactions. People with immunological urticaria should note how ...

Medically reviewed by Corinne Savides Happel, MD A rash around a child's mouth is not usually not due to food allergies. It ...

Resubmission of the supplemental biologics license application provided more data on improvement in hives and itching in ...

Chronic spontaneous urticaria is chronic inflammatory skin disease driven in part by type 2 inflammation, which causes sudden ...

As temperatures rise and outdoor activities increase, Clark County officials are warning residents of pissbleAccording to the ...

According to Doctor Michael, you might have heard the mysterious rash be called 'hives' before ... a bee or something you've eaten, like an allergic reaction. Doctor Michael continued explaining ...

Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose hives ...

The FDA approved dupilumab for the treatment of patients 12 years and older with chronic spontaneous urticaria who remain ...

The CSU indication is the seventh disease driven in part by underlying type 2 inflammation in which Dupixent has received approval.